L. Ciuffreda

940 total citations
23 papers, 333 citations indexed

About

L. Ciuffreda is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, L. Ciuffreda has authored 23 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in L. Ciuffreda's work include Bone health and treatments (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). L. Ciuffreda is often cited by papers focused on Bone health and treatments (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). L. Ciuffreda collaborates with scholars based in Italy, Spain and United States. L. Ciuffreda's co-authors include Matteo Scoletta, Marco Mozzati, Anna Maria Vandone, Michela Donadio, Mara Ardine, Vito Michele Fazio, Paola Parrella, Vanna Maria Valori, Barbara Pasculli and Paolo Graziano and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

L. Ciuffreda

22 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Ciuffreda Italy 8 208 119 96 74 54 23 333
Mara Ardine Italy 11 285 1.4× 127 1.1× 52 0.5× 83 1.1× 25 0.5× 19 371
Nilesh Mehta United States 5 319 1.5× 71 0.6× 82 0.9× 27 0.4× 55 1.0× 6 389
Elisabeth Melbinger‐Zeinitzer Austria 6 179 0.9× 50 0.4× 64 0.7× 62 0.8× 26 0.5× 6 211
Haolin Yan China 10 97 0.5× 7 0.1× 66 0.7× 63 0.9× 109 2.0× 21 302
Ankur Modi United States 6 273 1.3× 98 0.8× 63 0.7× 28 0.4× 79 1.5× 10 395
E. Seyrek Türkiye 10 79 0.4× 9 0.1× 47 0.5× 35 0.5× 31 0.6× 22 263
Amanda Goldrick Australia 8 166 0.8× 24 0.2× 83 0.9× 28 0.4× 29 0.5× 11 245
Marion Hindemith Germany 5 46 0.2× 10 0.1× 23 0.2× 123 1.7× 74 1.4× 5 267
Şeyda Gündüz Türkiye 9 185 0.9× 4 0.0× 31 0.3× 79 1.1× 47 0.9× 15 251
Stephanie Petrone United States 3 452 2.2× 141 1.2× 36 0.4× 50 0.7× 94 1.7× 5 511

Countries citing papers authored by L. Ciuffreda

Since Specialization
Citations

This map shows the geographic impact of L. Ciuffreda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Ciuffreda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Ciuffreda more than expected).

Fields of papers citing papers by L. Ciuffreda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Ciuffreda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Ciuffreda. The network helps show where L. Ciuffreda may publish in the future.

Co-authorship network of co-authors of L. Ciuffreda

This figure shows the co-authorship network connecting the top 25 collaborators of L. Ciuffreda. A scholar is included among the top collaborators of L. Ciuffreda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Ciuffreda. L. Ciuffreda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parrella, Paola, Raffaela Barbano, Andrea Fontana, et al.. (2024). Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer. Biomedicines. 12(11). 2625–2625. 3 indexed citations
2.
Bazzichetto, Chiara, Isabella Sperduti, L. Ciuffreda, et al.. (2021). P-267 Interleukin-8 levels as a predictor of colorectal cancer patient prognosis. Annals of Oncology. 32. S188–S189. 1 indexed citations
3.
Fontana, Andrea, Raffaela Barbano, Elisa Dama, et al.. (2021). Combined analysis of miR-200 family and its significance for breast cancer. Scientific Reports. 11(1). 2980–2980. 32 indexed citations
4.
Rosati, Gerardo, Francesca Galli, Sara Lonardi, et al.. (2020). 399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial. Annals of Oncology. 31. S410–S411. 1 indexed citations
5.
Bazzichetto, Chiara, et al.. (2017). Tumor-stroma interactions and response to targeted agents in preclinical models of colorectal cancer (CRC). Annals of Oncology. 28. v169–v169. 1 indexed citations
6.
Crinò, Lucio, Paolo Bidoli, F. Roila, et al.. (2017). Efficacy and safety data from patients with advanced non-squamous NSCLC and brain metastases from the nivolumab expanded access programme (EAP) in Italy. Annals of Oncology. 28. v469–v469. 4 indexed citations
7.
Labianca, Roberto, Sara Lonardi, Gerardo Rosati, et al.. (2017). FOLFOX4/XELOX in stage II–III colon cancer: Efficacy and safety results of the Italian Three Or Six Colon Adjuvant (TOSCA) trial. Annals of Oncology. 28. v614–v614. 2 indexed citations
8.
Barbano, Raffaela, Barbara Pasculli, Andrea Fontana, et al.. (2017). Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients. Scientific Reports. 7(1). 45283–45283. 44 indexed citations
9.
Roila, Fausto, Benedetta Ruggeri, Enzo Ballatori, et al.. (2015). Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. Annals of Oncology. 26(6). 1248–1253. 24 indexed citations
10.
Cremolini, Chiara, Fotios Loupakis, Daniele Rossini, et al.. (2014). Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis. Annals of Oncology. 25. iv175–iv175. 2 indexed citations
11.
Taı̈eb, Julien, Roberto Bordonaro, Katia Bencardino, et al.. (2014). Quality of Life (Qol) on the Aflibercept/Folfiri Regimen: 4Th Interim Analysis of the Global Aflibercept Safety and Health-Related Qol Program. Annals of Oncology. 25. iv180–iv180. 1 indexed citations
12.
Saracino, Silvia, Rosa Angela Canuto, M. Maggiora, et al.. (2012). Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model. Journal of Oral Pathology and Medicine. 41(10). 788–792. 22 indexed citations
13.
Vandone, Anna Maria, Michela Donadio, Marco Mozzati, et al.. (2011). Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Annals of Oncology. 23(1). 193–200. 114 indexed citations
14.
Lancia, Massimo, et al.. (2011). Problem of differential diagnosis between Crohn’s disease and colitis in Behçet’s disease: a case report. Reumatismo. 62(2). 127–30. 1 indexed citations
15.
Rampino, Monica, Umberto Ricardi, C. Barone, et al.. (2010). Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial. Clinical Oncology. 23(2). 134–140. 33 indexed citations
16.
Marinis, Filippo de, Akin Atmaca, Marcello Tiseo, et al.. (2010). Deacetylase inhibitor (DACI) panobinostat in relapsed small cell lung cancer (SCLC) patients: Results of a multicenter phase II trial.. Journal of Clinical Oncology. 28(15_suppl). e17521–e17521. 3 indexed citations
17.
Barone, C., Nadia Birocco, Monica Rampino, et al.. (2008). Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.. PubMed. 28(2B). 1285–91. 3 indexed citations
18.
Roato, Ilaria, L Buffoni, Paraskevas Lybéris, et al.. (2007). Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer. Lung Cancer. 61(1). 109–116. 26 indexed citations
19.
Fusco, Vittorio, Cinzia Ortega, L. Ciuffreda, et al.. (2006). Bisphosphonates (BP)-related osteonecrosis of the jaw (ONJ): Clinical experience of the “Rete Oncologica di Piemonte e Valle d’Aosta” network. Journal of Clinical Oncology. 24(18_suppl). 18584–18584. 2 indexed citations
20.
Giaccone, Giuseppe, et al.. (1987). Bone Marrow Evaluation in Small Cell Carcinoma of the Lung. Acta Oncologica. 26(3). 185–188. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mara Ardine Breakdown of academic impact, for papers by Nilesh Mehta Breakdown of academic impact, for papers by Elisabeth Melbinger‐Zeinitzer Breakdown of academic impact, for papers by Haolin Yan Breakdown of academic impact, for papers by Ankur Modi Breakdown of academic impact, for papers by E. Seyrek Breakdown of academic impact, for papers by Amanda Goldrick Breakdown of academic impact, for papers by Marion Hindemith Breakdown of academic impact, for papers by Şeyda Gündüz Breakdown of academic impact, for papers by Stephanie Petrone
Rankless by CCL
2026